About POCARD Ltd.
We are working towards the development of products for therapeutic apheresis and implementation of the technologies of therapeutic apheresis in clinical practice.
Adsorption columns of our company are used to treat a wide range of diseases in almost all fields of medicine and intended.
Develop and promote the technology of therapeutic apheresis in the practical healthcare, as well as to support a high status and international recognition of the scientific results of Russian researchers in the field of extracorporeal technologies.
History of the company
The manufacturing activity of the company is mainly devoted to the production of adsorption columns for therapeutic apheresis.
The company possesses a technology of aseptic manufacturing of products using biological components that do not require sterilization.
Elaboration and production of adsorption columns are conducted in accordance with ISO 13485:2016 requirements and Medical Device Directive MDD 93/42/EEC.
The quality system is certified by the international audit company ITC (designated person 1023).
The quality of manufacturing and production of POCARD Ltd. in compliance with the requirements of European quality standards.
The research group of POCARD Ltd. is engaged in identification of pathogenic molecules in human organism and potential targets of extracorporeal therapy useful for the treatment of different diseases.
Furthermore, our group of scientists works towards the development of synthesis methods for sorbents designed to eliminate pathogenic components from the human blood.